Top-Rated Biotech Stocks

It's typically feast or famine when it comes to biotech stocks, but one big winner can more than make up for a bunch of losers. The secret is finding well-run companies delivering high-quality drugs before the market finds them.

Of course, that's easier said than done, and some biotech companies are already beyond their high-growth stage. Nevertheless, in that spirit, we'll use the aggregate intelligence of the 105,000-plus investors participating in Motley Fool CAPS to find biotech stocks that the community likes -- those with four- and five-star ratings. The community's approval could be a sign that further research is in order.

Here are five such stocks:


Market Cap

% CAPS All-Star Bulls

CAPS Rating
(Out of 5)

CAPS Research

Amgen (Nasdaq: AMGN  )

$46.8 B




Genentech (NYSE: DNA  )

$77.7 B




Genzyme (Nasdaq: GENZ  )

$17.4 B




ViroPharma (Nasdaq: VPHM  )

$697 M




Gilead Sciences (Nasdaq: GILD  )

$49.0 B




Source: Motley Fool CAPS, as of June 11, 2008.

Come and join us on CAPS to learn more about these and countless other interesting stock ideas. Sign up for free.

Disclosure is important to us here at The Motley Fool. The stocks mentioned in this article received their CAPS star ratings from participants in The Motley Fool's CAPS service. No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated by identifying the stocks rated by the CAPS community and by buyers in today's market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool's disclosure policy.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 663351, ~/Articles/ArticleHandler.aspx, 10/24/2016 12:12:42 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,229.47 83.76 0.46%
S&P 500 2,150.24 9.08 0.42%
NASD 5,301.11 43.71 0.83%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 11:56 AM
AMGN $158.84 Up +0.33 +0.21%
Amgen CAPS Rating: ****
DNA $94.97 Down +0.00 +0.00%
Genentech CAPS Rating: ****
GENZ.DL $76.25 Down +0.00 +0.00%
Genzyme Corp CAPS Rating: ****
GILD $74.50 Up +0.21 +0.28%
Gilead Sciences CAPS Rating: *****
VPHM.DL $0.00 Down +0.00 +0.00%
ViroPharma CAPS Rating: ***